January 2020 : Link

The Telegraph wrote about our ongoing pivotal (phase 3 equivalent) Alzheimer’s clinical trial with 228 participants recently. This article is a synopsis of the current stage of our clinical trial, along with the potential our technology has as a therapy for this neurodegenerative disease.

Please note that we’re still undergoing clinical research and do not claim to be a cure or therapy for this disease until proper authorization by relevant governing bodies.